Search Medical Condition
Please enter condition
Please choose location from dropdown

Depression Clinical Trials

A listing of Depression medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (1247) clinical trials

California Neuroscience Research is conducting a research study to evaluate an investigational medication in persons with treatment resistant Major Depressive Disorder. Study Description A Randomized, Double-blind, Active- controlled Trial to Assess the Efficacy and Safety of Administered Orally to Subjects with Treatment Resistant Major Depressive Disorder.

Phase N/A

The purpose of this research study is to investigate brain changes in adolescents who are currently experiencing depressive and/or anxiety symptoms and have a family history of bipolar disorder. Participants will be randomized to escitalopram and psychotherapy or placebo and psychotherapy for 16-week treatment.

Phase N/A

The purpose of the research study is to determine if nitrous oxide is an effective treatment for treatment-resistant bipolar depression. Participation includes 17 study visits. There will be randomization to inhalation of nitrous oxide gas or placebo, questionnaires, and blood and urine tests. Up to $320 is provided.visit. Risks and ...

Phase N/A

A Research Study is being conducted to evaluate an investigational product to be used for the treatment of Major Depressive Disorder (or MDD) in women. Qualified participants receive study-related care, and exams at no charge, in addition to compensation for time and effort.

Phase N/A

Adolescent Non-Drug Depression Study designed to study the safety and effectiveness of a non-drug treatment in adolescents with Major Depressive Disorder.

Phase N/A

To determine if SAGE-547 Injection infused intravenously for 60 hours reduces depressive symptoms in subjects with postpartum depression (PPD) compared to placebo injection

Phase N/A

A randomized, double-blind, active-controlled, multicenter study in male and female adult subjects with TRD to assess the efficacy, safety, and tolerability of flexibly dosed intranasal esketamine plus a newly initiated oral antidepressant compared with a newly initiated oral antidepressant plus intranasal placebo

Phase N/A

To assess the long-term safety and tolerability of ALKS 5461 for use as an adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD)

Phase

To evaluate the efficacy of ALKS 5461 for the adjunctive treatment of major depressive disorder (MDD) in adults who have an inadequate response to antidepressant therapy (ADT). To evaluate the safety and tolerability of ALKS 5461 in adults who have MDD and an inadequate response to ADT.

Phase